Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors
Clinical trial NCT05831033 · RECRUITING
Trial details
- NCT number
- NCT05831033
- Sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-23
- Primary completion
- 2027-02-15
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.